Free Trial

KORU Medical Systems (KRMD) Competitors

KORU Medical Systems logo
$2.75 0.00 (0.00%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$2.74 0.00 (-0.18%)
As of 05/1/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KRMD vs. CLPT, DCTH, NPCE, SMLR, TCMD, NNOX, STIM, SMTI, ZIMV, and SNWV

Should you be buying KORU Medical Systems stock or one of its competitors? The main competitors of KORU Medical Systems include ClearPoint Neuro (CLPT), Delcath Systems (DCTH), NeuroPace (NPCE), Semler Scientific (SMLR), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), ZimVie (ZIMV), and SANUWAVE Health (SNWV). These companies are all part of the "medical equipment" industry.

KORU Medical Systems vs.

ClearPoint Neuro (NASDAQ:CLPT) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

KORU Medical Systems received 20 more outperform votes than ClearPoint Neuro when rated by MarketBeat users. However, 89.29% of users gave ClearPoint Neuro an outperform vote while only 64.29% of users gave KORU Medical Systems an outperform vote.

CompanyUnderperformOutperform
ClearPoint NeuroOutperform Votes
25
89.29%
Underperform Votes
3
10.71%
KORU Medical SystemsOutperform Votes
45
64.29%
Underperform Votes
25
35.71%

30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 6.1% of ClearPoint Neuro shares are held by insiders. Comparatively, 20.6% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ClearPoint Neuro presently has a consensus target price of $25.00, indicating a potential upside of 79.73%. KORU Medical Systems has a consensus target price of $4.70, indicating a potential upside of 70.91%. Given ClearPoint Neuro's higher probable upside, equities analysts plainly believe ClearPoint Neuro is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ClearPoint Neuro
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
KORU Medical Systems
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00

KORU Medical Systems has a net margin of -37.42% compared to ClearPoint Neuro's net margin of -59.64%. KORU Medical Systems' return on equity of -24.60% beat ClearPoint Neuro's return on equity.

Company Net Margins Return on Equity Return on Assets
ClearPoint Neuro-59.64% -62.10% -38.39%
KORU Medical Systems -37.42%-24.60%-16.87%

In the previous week, ClearPoint Neuro had 3 more articles in the media than KORU Medical Systems. MarketBeat recorded 7 mentions for ClearPoint Neuro and 4 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.07 beat ClearPoint Neuro's score of 0.68 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ClearPoint Neuro
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
KORU Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

ClearPoint Neuro has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.

KORU Medical Systems has higher revenue and earnings than ClearPoint Neuro. KORU Medical Systems is trading at a lower price-to-earnings ratio than ClearPoint Neuro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ClearPoint Neuro$31.39M12.40-$22.09M-$0.70-19.87
KORU Medical Systems$33.65M3.77-$13.74M-$0.12-22.92

Summary

KORU Medical Systems beats ClearPoint Neuro on 12 of the 17 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KRMD vs. The Competition

MetricKORU Medical SystemsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$126.89M$4.33B$5.53B$7.93B
Dividend YieldN/A39.93%5.11%4.22%
P/E Ratio-11.0030.0322.5118.54
Price / Sales3.7755.31397.62103.30
Price / CashN/A51.0838.1834.62
Price / Book6.116.056.734.25
Net Income-$13.74M$68.71M$3.22B$248.18M
7 Day Performance11.34%-0.24%1.38%1.03%
1 Month Performance7.84%-2.90%2.79%2.70%
1 Year Performance15.55%21.00%15.41%4.05%

KORU Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KRMD
KORU Medical Systems
3.2515 of 5 stars
$2.75
flat
$4.70
+70.9%
+22.2%$126.89M$33.65M-11.0080Upcoming Earnings
News Coverage
Positive News
CLPT
ClearPoint Neuro
2.1066 of 5 stars
$14.71
+0.1%
$25.00
+70.0%
+156.6%$411.59M$31.39M-21.32110News Coverage
DCTH
Delcath Systems
2.8535 of 5 stars
$12.00
-0.9%
$22.75
+89.6%
+123.7%$401.20M$37.21M-8.8960Short Interest ↑
Positive News
NPCE
NeuroPace
3.8684 of 5 stars
$11.62
+4.2%
$15.20
+30.8%
-15.6%$380.59M$79.91M-11.62170Upcoming Earnings
Short Interest ↓
SMLR
Semler Scientific
3.1122 of 5 stars
$35.37
-4.0%
$71.00
+100.7%
+27.6%$339.45M$56.29M7.20120Upcoming Earnings
Gap Up
TCMD
Tactile Systems Technology
2.9437 of 5 stars
$14.17
-2.8%
$18.00
+27.0%
-3.6%$335.35M$292.98M20.24980Upcoming Earnings
NNOX
Nano-X Imaging
2.5741 of 5 stars
$5.15
-1.9%
$12.00
+133.0%
-45.5%$297.56M$11.28M-6.06190Positive News
STIM
Neuronetics
1.2729 of 5 stars
$4.45
-0.7%
$5.50
+23.6%
+25.5%$292.88M$74.89M-3.62180Upcoming Earnings
News Coverage
SMTI
Sanara MedTech
2.0254 of 5 stars
$31.64
-0.3%
$48.50
+53.3%
+3.2%$281.22M$86.67M-31.9660News Coverage
Positive News
ZIMV
ZimVie
2.4847 of 5 stars
$9.31
-1.4%
$19.50
+109.5%
-41.7%$259.26M$449.75M-0.712,700Positive News
Gap Up
SNWV
SANUWAVE Health
N/A$27.40
-3.8%
N/AN/A$234.24M$32.63M-7.0340Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:KRMD) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners